29 news items
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines - BIIB
BIIB
15 Jun 24
("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare Conference. While speaking at the conference, Defendant Viehbacher discussed challenges
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Charge, and Fastly and Encourages Investors to Contact the Firm
BIIB
CRGEQ
FSLY
13 Jun 24
CEO Defendant Christopher A. Viehbacher ("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare Conference. While speaking
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines – BIIB
BIIB
13 Jun 24
. On January 8, 2024, Biogen's CEO Defendant Christopher A. Viehbacher ("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Charge, and Fastly and Encourages Investors to Contact the Firm
BIIB
CRGEQ
FSLY
9 Jun 24
A. Viehbacher ("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare Conference. While speaking at the conference, Defendant Viehbacher
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
BIIB
9 Jun 24
A. Viehbacher ("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare Conference. While speaking at the conference, Defendant Viehbacher discussed
b31wiotlsk639yq8pe5t1ehf9ml9l9251dia9605zx1r3adldlf45rsd
BIIB
7 Jun 24
A. Viehbacher ("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare Conference. While speaking at the conference, Defendant Viehbacher discussed
fgk47zgza52ep4xix6v8c0f83zm92jhyx6qnk
BIIB
CRGEQ
FSLY
5 Jun 24
("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare Conference. While speaking at the conference, Defendant Viehbacher discussed
mry53fz4lu3bh909gnf47 mvvzzi
BIIB
5 Jun 24
. On January 8, 2024, Biogen's CEO Defendant Christopher A. Viehbacher ("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare
gn0s7zi4af1zo r0e6ac
BIIB
4 Jun 24
A. Viehbacher ("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare Conference. While speaking at the conference, Defendant Viehbacher discussed
dum8jyu3jfo3bb1d4r8ge3rgthkguacpyl437ie5u366ekj41
BIIB
4 Jun 24
8, 2024, Biogen's CEO Defendant Christopher A. Viehbacher ("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare Conference. While
p8b8x1lnuxhnb9l3wye5o46s58lqv4nq7nndkqqvmjegc52
BIIB
3 Jun 24
") attended the J.P. Morgan 42nd Annual Healthcare Conference. While speaking at the conference, Defendant Viehbacher discussed challenges with the launch
wh607nn8 beyg40kp
BIIB
1 Jun 24
the J.P. Morgan 42nd Annual Healthcare Conference. While speaking at the conference, Defendant Viehbacher discussed challenges with the launch of Leqembi
hr4c mfet161
BIIB
1 Jun 24
A. Viehbacher ("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare Conference. While speaking at the conference, Defendant Viehbacher discussed
8xwtroo 86x
BIIB
30 May 24
Christopher A. Viehbacher ("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare Conference. While
85c9bt5mwcn6bmx45dmqjbtv38obkl 3u
BIIB
29 May 24
A. Viehbacher ("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare Conference. While speaking at the conference, Defendant Viehbacher discussed
ligxky0snp1 vbt3s5
BIIB
28 May 24
the J.P. Morgan 42nd Annual Healthcare Conference. While speaking at the conference, Defendant Viehbacher discussed challenges with the launch of Leqembi
aozwfbvblkgt3a59n4g0c5vc705
BIIB
28 May 24
. On January 8, 2024, Biogen's CEO Defendant Christopher A. Viehbacher ("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare
9gxchnr1dxunuofvj4putfkli m3yrtm6bjlzef
BIIB
24 May 24
A. Viehbacher ("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare Conference. While speaking at the conference, Defendant Viehbacher
86qpm983i
BIIB
23 May 24
") attended the J.P. Morgan 42nd Annual Healthcare Conference. While speaking at the conference, Defendant Viehbacher discussed challenges with the launch
8k3k98t9i73zcedl5a1 usmvq5vzigyfymfl4psuxrtq0teu0nwl
BIIB
22 May 24
("Viehbacher") attended the J.P. Morgan 42nd Annual Healthcare Conference. While speaking at the conference, Defendant Viehbacher discussed challenges